Our live Investing Matters Podcast Special which took place at the Master Investor Show discussing 'How undervalued is the UK stock market?', has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Synairgen unveils positive clinical trial data

Wed, 07th Sep 2022 07:59

(Sharecast News) - Respiratory drug discovery firm Synairgen has announced positive findings from a clinical trial into its experimental antiviral treatment.

The firm said analysis of phase 2 clinical trial in chronic obstructive pulmonary disease (COPD) patients with a confirmed respiratory viral infection showed the inhaled treatment - known as SNG001 - could accelerate viral clearance from the lung.

In particular, the results suggested that human rhinovirus - the most frequently detected virus - was cleared more rapidly in patients treated with SNG001 than the placebo.

Richard Marsden, Synairgen chief executive, said: "Our new data from COPD patients shows that SNG001 can accelerate viral clearance from the lung and builds on our existing data supporting SNG001's mechanism of action and our focus on severe viral lung infections.

"This additional assessment supports continued and further investigation of SNG001 as a possible broad-spectrum antiviral."

Synairgen's SG015 trial in COPD patients was paused in early 2020 because of the pandemic, with 109 patients recruited out of the 120 targeted. Interim analysis of that data was first reported in September 2020.

Shares in the AIM-listed firm were ahead 7% at 23.6p as at 0830 BST on Wednesday.

Related Shares

More News
11 Oct 2023 11:19

IN BRIEF: Synairgen names Phytome's Joseph Colliver as CFO

Synairgen PLC - Southampton, England-based drug discovery and biotechnology firm developing SNG001 antiviral treatment for lung infections - Appoints ...

11 Oct 2023 10:26

Synairgen names Joseph Colliver as CFO

(Sharecast News) - Drug discovery firm Synairgen revealed on Wednesday that it had tapped Joseph Colliver to take over as chief financial officer.

3 Oct 2023 09:59

Synairgen promotes Marcin Mankowski to chief medical officer

(Alliance News) - Synairgen PLC on Tuesday promoted Marcin Mankowski to chief medical officer, effective immediately.

21 Sep 2023 13:48

IN BRIEF: Synairgen narrows interim loss on reduced R&D spending

Synairgen PLC - Southampton, England-based drug discovery and biotechnology firm developing SNG001 antiviral treatment for lung infections - Pretax lo...

22 Jun 2023 15:44

UK shareholder meetings calendar - next 7 days

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.